Search research articles
Contact Us
Filters
Showing results (21-30 of 116) with videos related to
Page
of 12
Sort By:
Neural Regeneration Research
|
July 8, 2022
<i>Globodera pallida</i>, a non-transgenic invertebrate as a new model for investigating Alzheimer's disease (and other proteinopathies)?
Norah A Althobaiti, Farid Menaa, Johnathan J Dalzell, et al.
British Journal of Pharmacology
|
April 26, 2016
Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes
Elaine Cowan, Kerry J Burch, Brian D Green, et al.
Journal of Food Science and Technology
|
July 6, 2019
Studies on in vitro bioavailability and starch hydrolysis in zinc fortified ready-to-eat parboiled rice (<i>komal chawal</i>)
Elizabeth D Wahengbam, Arup Jyoti Das, Brian D Green, et al.
British Journal of Pharmacology
|
September 19, 2014
Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes
Mitchel Tate, Aaron Chong, Emma Robinson, et al.
Journal of Cellular Physiology
|
June 23, 2010
Inward rectifier potassium channels in the HL-1 cardiomyocyte-derived cell line
Dana Goldoni, YouYou Zhao, Brian D Green, et al.
European Journal of Nutrition
|
January 14, 2014
Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential
Harsh Panwar, Danielle Calderwood, Irene R Grant, et al.
Peptides
|
January 29, 2016
Naturally-occurring TGR5 agonists modulating glucagon-like peptide-1 biosynthesis and secretion
Laila Jafri, Samreen Saleem, Danielle Calderwood, et al.
Current Pharmaceutical Design
|
December 8, 2004
Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents
Brian D Green, Victor A Gault, Finbarr P M O'harte, et al.
Peptides
|
September 6, 2017
Detailed characterisation of STC-1 cells and the pGIP/Neo sub-clone suggests the incretin hormones are translationally regulated
Anna L Gillespie, Xiaobei Pan, Anna Marco-Ramell, et al.
Molecular Nutrition & Food Research
|
March 31, 2010
Acute and chronic effects of dietary fatty acids on cholecystokinin expression, storage and secretion in enteroendocrine STC-1 cells
Katharine V Hand, Christine M Bruen, Fiona O'Halloran, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 116) with videos related to
Sort By:
Page
of 12
Neural Regeneration Research
|
July 8, 2022
<i>Globodera pallida</i>, a non-transgenic invertebrate as a new model for investigating Alzheimer's disease (and other proteinopathies)?
Norah A Althobaiti, Farid Menaa, Johnathan J Dalzell, et al.
British Journal of Pharmacology
|
April 26, 2016
Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes
Elaine Cowan, Kerry J Burch, Brian D Green, et al.
Journal of Food Science and Technology
|
July 6, 2019
Studies on in vitro bioavailability and starch hydrolysis in zinc fortified ready-to-eat parboiled rice (<i>komal chawal</i>)
Elizabeth D Wahengbam, Arup Jyoti Das, Brian D Green, et al.
British Journal of Pharmacology
|
September 19, 2014
Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes
Mitchel Tate, Aaron Chong, Emma Robinson, et al.
Journal of Cellular Physiology
|
June 23, 2010
Inward rectifier potassium channels in the HL-1 cardiomyocyte-derived cell line
Dana Goldoni, YouYou Zhao, Brian D Green, et al.
European Journal of Nutrition
|
January 14, 2014
Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential
Harsh Panwar, Danielle Calderwood, Irene R Grant, et al.
Peptides
|
January 29, 2016
Naturally-occurring TGR5 agonists modulating glucagon-like peptide-1 biosynthesis and secretion
Laila Jafri, Samreen Saleem, Danielle Calderwood, et al.
Current Pharmaceutical Design
|
December 8, 2004
Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents
Brian D Green, Victor A Gault, Finbarr P M O'harte, et al.
Peptides
|
September 6, 2017
Detailed characterisation of STC-1 cells and the pGIP/Neo sub-clone suggests the incretin hormones are translationally regulated
Anna L Gillespie, Xiaobei Pan, Anna Marco-Ramell, et al.
Molecular Nutrition & Food Research
|
March 31, 2010
Acute and chronic effects of dietary fatty acids on cholecystokinin expression, storage and secretion in enteroendocrine STC-1 cells
Katharine V Hand, Christine M Bruen, Fiona O'Halloran, et al.
Page
of 12